Martin Babler
CIK 1435618 · President, CEO and Chairman · last filed 2026-06-10
Martin Babler is a President, CEO and Chairman who has filed 32 SEC Form 4 insider transactions across 7 companies since 2008. The most recent filing, for PRLD, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$3.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.64M
7
32
-$3.34M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRLD | Director | — | $4.49 | — | $0 | 6 | 2026-06-10 |
| ALMS | President, CEO and Chairman | 109,454 | $24.15 | $2.64M | $100.7K | 5 | 2026-01-28 |
| 89bio, Inc. (ETNB) Delisted | Director | — | $14.84 | — | $0 | 3 | 2025-10-30 |
| Neurogene Inc. (NLTX) Delisted | Director | — | $13.96 | — | $0 | 4 | 2023-06-09 |
| Principia Biopharma Inc. (PRNB) Delisted | President, CEO | 0 | — | — | -$3.45M | 6 | 2020-09-28 |
| ZS Pharma, Inc. (ZSPH) Delisted | Director | — | — | — | $0 | 1 | 2015-06-25 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Director | — | $0.04 | — | $0 | 6 | 2013-06-13 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | PRLD | Grant (A) | — | $0 | EDGAR |
| 2026-01-28 | ALMS | Grant (A) | — | $0 | EDGAR |
| 2025-10-30 | 89bio, Inc. (ETNB) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-07-31 | ALMS | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | PRLD | Grant (A) | — | $0 | EDGAR |
| 2025-04-03 | ALMS | Buy (P) | +15,650 | $100.7K | EDGAR |
| 2025-02-20 | ALMS | Grant (A) | — | $0 | EDGAR |
| 2025-02-05 | 89bio, Inc. (ETNB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-07-01 | ALMS | Mixed | — | $0 | EDGAR |
| 2024-06-18 | PRLD | Grant (A) | — | $0 | EDGAR |